How effective are the usual treatments for ulcerative colitis?

被引:50
作者
Bebb, JR [1 ]
Scott, BB [1 ]
机构
[1] Lincoln Cty Hosp, Dept Gastroenterol, Lincoln LN2 5QY, England
关键词
D O I
10.1111/j.1365-2036.2004.02018.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Details of the efficacy of the drugs used in ulcerative colitis are not readily available. Methods: We have reviewed all placebo-controlled trials of the commonly used drugs for both induction and maintenance of remission to determine the efficacy and to calculate the numbers needed to treat (NNTs) to achieve a specified benefit for each drug. Results: The drug response rates and the NNTs (with 95% CI) are tabulated for each drug. Conclusion: Corticosteroids give a remission rate of 68% in mild or moderate disease and an NNT for remission of 2 (95% CI 1.4-5) in mild disease. Intravenous hydrocortisone gives a remission rate of 60-73%. Aminosalicylates are relatively ineffective in inducing remission with an NNT of 10 (95% CI 7-21) improving to 8 (95% CI 5-20) if the dose greater than or equal to3 g daily. They are better at maintenance (NNT = 6; 95% CI 4-8). Intravenous ciclosporin is very effective in achieving remission in severe colitis with an NNT of 1.2 (95% CI 1-2.5). Although there is fairly good evidence that azathioprine is effective in maintaining remission and is used widely, there are no suitable placebo-controlled trials to calculate the NNT.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 40 条
[31]   COATED ORAL 5-AMINOSALICYLIC ACID THERAPY FOR MILDLY TO MODERATELY ACTIVE ULCERATIVE-COLITIS - A RANDOMIZED STUDY [J].
SCHROEDER, KW ;
TREMAINE, WJ ;
ILSTRUP, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (26) :1625-1629
[32]   ORAL MESALAMINE (ASACOL) FOR MILDLY TO MODERATELY ACTIVE ULCERATIVE-COLITIS - A MULTICENTER STUDY [J].
SNINSKY, CA ;
CORT, DH ;
SHANAHAN, F ;
POWERS, BJ ;
SESSIONS, JT ;
PRUITT, RE ;
JACOBS, WH ;
LO, SK ;
TARGAN, SR ;
CERDA, JJ ;
GREMILLION, DE ;
SNAPE, WJ ;
SABEL, J ;
JINICH, H ;
SWINEHART, JM ;
DEMICCO, MP .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) :350-355
[33]  
SUTHERLAND L, 2003, COCHRANE LIB
[34]   Effectiveness of cyclosporine A (CsA) in the treatment of active refractory ulcerative colitis (UC). [J].
Svanoni, F ;
Bonassi, U ;
Bagnolo, F ;
Caporuscio, S .
GASTROENTEROLOGY, 1998, 114 (04) :A1096-A1096
[35]  
TEXTER E C Jr, 1957, J Chronic Dis, V5, P347, DOI 10.1016/0021-9681(57)90093-0
[36]  
TRUELOVE SC, 1974, LANCET, V1, P1067
[37]  
TRUELOVE SC, 1978, LANCET, V2, P1086
[38]   CORTISONE IN ULCERATIVE COLITIS - PRELIMINARY REPORT ON A THERAPEUTIC TRIAL [J].
TRUELOVE, SC ;
WITTS, LJ .
BRITISH MEDICAL JOURNAL, 1954, 2 (4884) :375-378
[39]   OLSALAZINE IN MAINTENANCE OF CLINICAL REMISSION IN PATIENTS WITH ULCERATIVE-COLITIS [J].
WRIGHT, JP ;
OKEEFE, EA ;
CUMING, L ;
JASKIEWICZ, K .
DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) :1837-1842
[40]  
ZINBERG J, 1990, AM J GASTROENTEROL, V85, P562